Wydarzenia naukowe w których uczestniczyli nasi przedstawiciele na przestrzeni lat.
Annual Congress of the European Association of Nuclear Medicine (EANM’25), Barcelona, Hiszpania
Safer3: A Phase III Prospective, Multicenter, Open-label Study to Assess Diagnostic Efficacy of a Novel F-18 labelled Myocardial perfusion tracer, F-18-SYN2 (Knuuti J., Al-Mallah M.H., Słomka P.J. i inni)
The American Society of Nuclear Cardiology Annual Scientific Session (ASNC2025), Orlando, USA
Phase III Prospective Multicenter Study Assessing Diagnostic Efficacy of a [18F]-labeled Myocardial Perfusion Tracer [18F]SYN2. SAFER3 (Dziuk M., Knuuti J., Słomka P. i inni )
Annual Congress of the European Association of Nuclear Medicine (EANM’24), Hamburg, Niemcy
A Phase I study of [18F]SYN2, a new PET perfusion tracer in healthy subjects (Knuuti J., Kobylecka M., Kalliokoski K. i inni)
Open label, single arm, adaptive study assessing Safety and Accuracy of 18F-SYN2 – a novel PET myocardial perfusion tracer in patients with suspected functionally significant coronary stenoses – SAFER phase 2 clinical trial (Dziuk M., Kobylecka M., Chrapko B. i inni)
International Conference on Nuclear Cardiology and Cardiac CT (ICNC-CT2024), Sewilla, Hiszpania
Preclinical evaluation of [18F]SYN2, a novel radiotracer for myocardial perfusion imaging in PET (Krajewski S., Steczek Ł., Gotowicz K. i inni)
Safety, tolerability and diagnostic ability of a novel 18F-labelled tracer, [18F]SYN2, for PET myocardial perfusion imaging (SAFER) in patients with suspected coronary artery disease – phase II trial (Dziuk M., Knuuti J., Krajewski S. i inni)
Biodistribution, safety profile, and radiation dosimetry of [18F]SYN2, a new PET perfusion tracer in healthy subjects (Knuuti J., Kobylecka M., Kalliokoski K. i inni)
Annual Congress of the European Association of Nuclear Medicine (EANM’23), Wiedeń, Austria
A comparison of biodistribution and the patient dose estimation of [18F]FEPP and [18F]FEAO, potential radiotracers for PET myocardial perfusion imaging (Gotowicz K., Karczmarczyk U., Krajewski S. i inni)
Preclinical evaluation of [18F]FEAO, a novel radiotracer for myocardial perfusion imaging in PET (Dziuk M., Witkowska-Patena E., Krajewski S. i inni)